Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation

NCT00558597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-07-21

No results posted yet for this study

Summary

In patients with acute rejection after lung transplantation the peptide profile in broncho-alveolar lavage (BAL) and urine should be compared in order to identify a paradigm that allows an non-invasive rejection therapy.

Conditions

  • Rejection
  • Lung Transplantation

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jens Gottlieb, Dr. med. · Hannover Medical School

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558597 on ClinicalTrials.gov